Smartwatch with heart rate monitor icon on colorful diagonal striped background
Medtech Case Study

Patient Preference Study Informs Clinical Trial for Pediatric Ear Device

Caregiver Preference Data Shape Clinical Performance Goals for a Pediatric Ear Tube Device
 

Source
Value & Outcomes Spotlight

Link
Using Patient Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond
 

Description of Case Study

Smith+Nephew, a medtech company developing a first-of-a-kind tympanostomy tube (ear tube) combination drug-device product, conducted a patient preference study with parents of children who may require ear tube placement. The company used the patient preference information to help them understand the trade-offs that parents are willing to make when considering a more convenient office-based procedure performed under local anesthesia with a potentially lower success rate compared with traditional ear tube placement under general anesthesia in the operating room. The company used surveys and other methods to capture caregiver perspectives on treatment benefits, risks, and device-related attributes and to inform product development and regulatory decision-making.
 

Quick Facts

Organization name: Smith+Nephew
Organization type: large medtech company (250-plus employees)
Product category: therapeutic device or technology
Region(s) of patient engagement activities: not listed
Total product life cycle stage(s): discovery/preclinical, evaluation/authorization

 

Product Type(s)

medical devices:

  • implantable device
  • home-use device
  • therapeutic device
     

Product Medical Specialty Area(s)

  • ear, nose, throat
     

Stakeholders

  • medtech company: internal discovery/research and development teams
  • patients and caregivers, patient organizations
     

Methods and Sources of Patient Input

  • interviews/focus groups/surveys
  • patient preference information/studies
     

Impact of Patient Engagement

The patient preference study provided quantitative evidence about the trade-offs that caregivers were willing to make when evaluating treatment options for children requiring tympanostomy tubes and related ear interventions. By capturing which benefits, risks, and treatment characteristics were most important to families, the study demonstrated how patient preference information can complement traditional clinical evidence and can support product development and regulatory benefit-risk assessments. Ultimately, these preference study findings informed the effectiveness performance goal of a clinical study.
 

Lessons Learned

Stakeholders highlighted four key lessons following the completion of this patient preference study: 

  • Target outreach within the US Food and Drug Administration (FDA): To maximize efficiency, it is important to discuss studies with the appropriate experts at the FDA to avoid wasting limited time.
  • Apply rigor to patient preference research: When conducting a patient preference study, it should be treated like a clinical study and include elements such as a budget, timeline, and statistical rigor.
  • Leverage external expertise when needed: If a company lacks the proper expertise internally, it should identify the appropriate external partners to collaborate with.
  • Engage the FDA early to align expectations: It is most beneficial to engage with the FDA early in the process, especially for companies with limited financial resources and time.